full

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public Offering

KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare…

23 hours ago

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

March 13, 2025 17:00 ET  | Source: IRIDEX Corporation MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ:…

3 days ago

SCYNEXIS Reports Full Year 2024 Financial Resultsand Provides Corporate Update

March 12, 2025 17:08 ET  | Source: Scynexis The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in…

3 days ago

Brag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment Option

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (Nasdaq: TBH) ("Brag House" or the "Company") today…

4 days ago

LZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment Option

HUZHOU CITY, China, March 11, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings Limited (NASDAQ: LZMH) (“LZ Technology” or the “Company”),…

4 days ago

Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

March 07, 2025 17:30 ET  | Source: Better Choice Company Inc. TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Better…

7 days ago

zSpace Announces Date Change for its Conference Call to Discuss Fourth Quarter and Full Year 2024 Results

March 07, 2025 16:05 ET  | Source: zSpace, Inc. SAN JOSE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- zSpace (Nasdaq:…

1 week ago

BioSyent Schedules Fourth Quarter and Full Year 2024 Earnings Release for March 13, 2025

March 06, 2025 17:45 ET  | Source: BioSyent Inc. MISSISSAUGA, Ontario, March 06, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”,…

1 week ago

Vireo Growth Inc. Announces Fourth Quarter and Full Year 2024 Results

– Company achieves record revenue, gross profit margin and operating income in fiscal year 2024 – – FY24 revenue of…

2 weeks ago

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

March 04, 2025 07:00 ET  | Source: Seres Therapeutics, Inc. CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) --  Seres Therapeutics,…

2 weeks ago